Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Datasets submission for ILB_CMBAN-HiSeq_b37 - samples

ABSTRACT: Whole genome sequencing and genotyping of samples from CMBAN (Bantu from Cameroon)

PROVIDER: EGAD00001005012 | EGA |

REPOSITORIES: EGA

ACCESS DATA

Json Xml

Similar Datasets

Datasets submission for ILB_CMSBA-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from CMSBA (Semibantu from Cameroon)

| EGAD00001005013 | EGA

Datasets submission for ILB_TZWAS-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from TZWAS (Wasaamba from Tanzania)

| EGAD00001005014 | EGA

Datasets submission for ILB_TZPAR-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from TZPAR (Pare from Tanzania)

| EGAD00001005016 | EGA

Datasets submission for ILB_TZCHA-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from TZCHA (Chagga from Tanzania)

| EGAD00001005015 | EGA

Datasets submission for ILB_BFMOS-HiSeq_b37 - samples

Project description:Whole genome sequencing and genotyping of samples from BFMOS (Mossi from Burkina faso)

| EGAD00001005011 | EGA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Genomic variation in Mozambique and Angola: Contribution to the Bantu Expansion

Project description:We seek to investigate the genetic relationships between different Bantu-speaking populations and the migratory routes they followed during various phases of the Bantu expansion. Genomic and whole genome amplified DNA were genotyped on the Illumina InfiniumOmni2.5Exome-8v1.3 array. For quality control filtering, we used the PLINK v1.9 software and custom scripts.

2019-11-24 | E-MTAB-8450 | biostudies-arrayexpress

High concordance between SNPs identified by the porcine 60K BeadChip genotyping array (Illumina) and the assembly-versus-assembly method

Project description:Porcine 60K BeadChip genotyping arrays (Illumina) are increasingly being applied in pig genomics to validate SNPs identified by re-sequencing or assembly-versus-assembly method. Here we report that more than 98% SNPs identified from the porcine 60K BeadChip genotyping array (Illumina) were consistent with the SNPs identified from the assembly-based method. This result demonstrates that whole-genome de novo assembly is a reliable approach to deriving accurate maps of SNPs.

2016-07-05 | GSE83910 | GEO

SNP-array analysis in pediatric and adult T-cell lymphoblastic neoplasia

Project description:Illumina Infinium whole genome genotyping (WGG) arrays are increasingly being applied in cancer genomics to study gene copy number alterations and allele-specific aberrations such as loss-of-heterozygosity (LOH). Methods developed for normalization of WGG arrays have mostly focused on diploid, normal samples. However, for cancer samples genomic aberrations may confound normalization and data interpretation. Therefore, we examined the effects of the conventionally used normalization method for Illumina Infinium arrays when applied to cancer samples.

2026-03-31 | GSE288263 | GEO

MuSt multiomics - Integrated multi-omics of the human gut microbiome in a case study of familial type 1 diabetes

Project description:Multiomics of faecal samples collected from individuals in families with multiple cases of type 1 diabetes mellitus (T1DM) over 3 or 4 months. Metagenomic and metatranscriptomic sequencing and metaproteomics were carried out, as well as whole human genome sequencing. Phenotypic data is available.

2016-08-22 | PXD003791 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data